Ufp Technologies (UFPT) EPS (Weighted Average and Diluted) Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Ufp Technologies | 1.69 Bn | 1.67 Bn | 44.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32.43% |
| Dec 31, 2025 | 32.55% |
| Sep 30, 2025 | 39.46% |
| Jun 30, 2025 | 48.12% |
| Mar 31, 2025 | 33.56% |
| Dec 31, 2024 | 22.22% |
| Sep 30, 2024 | 22.98% |
| Jun 30, 2024 | 23.06% |
| Mar 31, 2024 | 26.81% |
| Dec 31, 2023 | 20.68% |
| Sep 30, 2023 | 22.10% |
| Jun 30, 2023 | 23.48% |
| Mar 31, 2023 | 39.55% |
| Dec 31, 2022 | 24.35% |
| Sep 30, 2022 | 61.92% |
| Jun 30, 2022 | 26.58% |
| Mar 31, 2022 | 16.36% |
| Dec 31, 2021 | 16.00% |
| Sep 30, 2021 | 6.21% |
| Jun 30, 2021 | 10.29% |
| Mar 31, 2021 | 29.67% |
| Dec 31, 2020 | 19.05% |
| Sep 30, 2020 | 7.39% |
| Jun 30, 2020 | -0.63% |
| Mar 31, 2020 | 17.72% |
| Dec 31, 2019 | 28.47% |
| Sep 30, 2019 | 20.93% |
| Jun 30, 2019 | 18.98% |
| Mar 31, 2019 | 11.52% |
| Dec 31, 2018 | 4.65% |
| Sep 30, 2018 | 6.43% |
| Jun 30, 2018 | 5.15% |
| Mar 31, 2018 | -3.71% |
| Dec 31, 2017 | -3.84% |
| Sep 30, 2017 | -9.07% |
| Jun 30, 2017 | -1.59% |
| Mar 31, 2017 | -1.89% |
| Dec 31, 2016 | -14.20% |
| Sep 30, 2016 | 1.12% |
| Jun 30, 2016 | -0.52% |
| Mar 31, 2016 | -14.06% |
| Dec 31, 2015 | -12.56% |
| Sep 30, 2015 | -4.36% |
| Jun 30, 2015 | -1.21% |